Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US faces 'new normal' of slower research pace under sequester

This article was originally published in Scrip

Executive Summary

The $1.5 billion the National Institutes of Health (NIH) lost from its fiscal year 2013 budget because of the across-the-board sequestration spending cuts that took effect on 27 March could become "the new normal" for the agency for at least the next decade, unless something is done to stop that budget-slashing bulldozer, said Senator Barbara Mikulski (Democrat-Maryland).

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC022005

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel